YUNGJIN PHARM. CO. LTD.

About YUNGJIN PHARM. CO. LTD.

Since its establishment in 1952, Yungjin Pharm. Co., Ltd. has been a pioneer in the Korean domestic pharmaceutical industry for national economic and improving public health with the lofty mission of saving humanity from disease and suffering through our medicines. As an affiliate of KT&G group, Yungjin plays a pivotal role in the bio pharmaceutical business within the group with outstan...

  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Licensee
Manufacturer/Innovator
Contact info

Products from YUNGJIN PHARM. CO. LTD. (3)

  • Candesartan Cilexetil API / Tab

    Product Candesartan Cilexetil API / Tab

    Yungjin Pharma offers a range of products which includes candesartan cilexetil. Specification: JP. Description: White crystalline powder. Assay: 99.0 ~ 101.0 % (as anhydrous basis). Packaging: 5, 10, 25 kg, Fiber drum. Candesartan is an antihypertensive in the angiotensin II receptor antagonist class. Cont...
  • Nintedanib API/Tab

    Product Nintedanib API/Tab

    Used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer
  • Cefmetazole Sodium / Inj

    Product Cefmetazole Sodium / Inj

    cephamycin antibiotic, usually grouped with the second-generation cephalosporins

YUNGJIN PHARM. CO. LTD. Resources (1)

  • Video OVERVIEW

    "Improvement of world health advances through Globalization and Partnerships"

    Company name : Yungjin Pharm. Co., Ltd
    CEO : Chae Joon, Lee
    Location : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
    Foundation date : October 10, 1952
    Representative products: Cephalosporin Antibiotic, Antipsychotic, Cardiovascular, Total Nutrition, and etc.


    Yungjin Pharm. Co., Ltd was established in 1952, has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century. With our inspiring mission statement, "To relieve the suffering of mankind from diseases with our innovative, effective and safe pharmaceutical products", we have shown our
    successful contribution not only within Korea, but also through global expansion. As a result, we have received a total of 25 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award and many more. These accomplishments demonstrate our sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.